These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 2145066
1. Antimyoclonic effect of MK-801: a possible role for NMDA receptors in developmental myoclonus of the neonatal rat. Pranzatelli MR. Clin Neuropharmacol; 1990 Aug; 13(4):329-38. PubMed ID: 2145066 [Abstract] [Full Text] [Related]
2. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. Witkin JM, Steele TD, Sharpe LG. J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180 [Abstract] [Full Text] [Related]
6. Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus. Tai KK, Truong DD. Brain Res; 2010 Jul 09; 1343():194-8. PubMed ID: 20434435 [Abstract] [Full Text] [Related]
7. Mechanism of action of antiepileptic and antimyoclonic drugs. Pranzatelli MR, Nadi NS. Adv Neurol; 1995 Jul 09; 67():329-60. PubMed ID: 8848979 [Abstract] [Full Text] [Related]
9. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo. Gilbert ME, Lasley SM. Neurotoxicol Teratol; 2007 Jul 09; 29(3):385-93. PubMed ID: 17350801 [Abstract] [Full Text] [Related]
10. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists. Maj J, Rogóz Z, Skuza G, Kołodziejczyk K. Pol J Pharmacol; 1994 Jul 09; 46(3):115-24. PubMed ID: 8000442 [Abstract] [Full Text] [Related]
11. Frequency-dependent inhibition in the dentate gyrus is attenuated by the NMDA receptor blocker MK-801 at doses that do not yet affect long-term potentiation. Rosenblum K, Maroun M, Richter-Levin G. Hippocampus; 1999 Jul 09; 9(5):491-4. PubMed ID: 10560918 [Abstract] [Full Text] [Related]
12. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L. Br J Pharmacol; 1998 Nov 09; 125(6):1258-66. PubMed ID: 9863655 [Abstract] [Full Text] [Related]
14. MK-801 can exacerbate or attenuate behavioral alterations associated with neonatal alcohol exposure in the rat, depending on the timing of administration. Thomas JD, Fleming And SL, Riley EP. Alcohol Clin Exp Res; 2001 May 09; 25(5):764-73. PubMed ID: 11371726 [Abstract] [Full Text] [Related]
15. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors. Zhong J, Gribkoff VK, Molinoff PB. Mol Pharmacol; 1996 Sep 09; 50(3):631-8. PubMed ID: 8794904 [Abstract] [Full Text] [Related]
16. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine. Witkin JM, Gasior M, Heifets B, Tortella FC. J Pharmacol Exp Ther; 1999 May 09; 289(2):703-11. PubMed ID: 10215643 [Abstract] [Full Text] [Related]